DJIA 18,094.25 -109.12 -0.60%
NASDAQ 4,961.92 -17.98 -0.36%
S&P 500 2,096.26 -11.52 -0.55%
market minute promo

Oncothyreon, Inc. (NASDAQ: ONTY)

1.60 -0.03 (-1.84%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ONTY $1.60 -1.84%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.63
Previous Close $1.63
Daily Range $1.60 - $1.65
52-Week Range $1.48 - $4.08
Market Cap $146.5M
P/E Ratio -4.18
Dividend (Yield) $0.00 (0.0%)
Volume 213,680
Average Daily Volume 765,166
Current FY EPS -$0.39

Sector

Healthcare

Industry

Drug Makers

Oncothyreon, Inc. (ONTY) Description

Oncothyreon Inc. is a clinical-stage biopharmaceutical company which is focused on the development of therapeutic products for the treatment of cancer. Website: http://www.oncothyreon.com/

News & Commentary

Why Oncotheryeon, Inc., OncoMed Pharmaceuticals, Inc., and Array BioPharma Inc. Stocks Jumped Today

Three biotechs climb after a competitor's trial success boosts hope across the HER-2 breast cancer treatment market

Weekly Analyst Highlights: Oil, Tesla On Readers' Minds

How Wall Street Is Reacting To The Pharmacyclics Rumor

Oncothyreon (ONTY) Stock a Solid Choice Right Now? - Tale of the Tape

Biotech Weekly: Top Ideas From The San Antonio Breast Cancer Symposium

Oncothyreon Up on Gaining License to Oncology Candidate - Analyst Blog

Health Care Sector Update for 12/12/2014: SNY, MEIP, ONTY

Oncothyreon Inc. (ONTY) in Focus: Stock Surges 10.1% - Tale of the Tape

Oncothyreon Inc. (ONTY) in Focus: Stock Surges 10.1% - Tale of the Tape

Oncothyreon And Celldex Therapeutics Announce Initiation Of Combination Immunotherapy Clinical Trial

Oncothyreon And Celldex Therapeutics Announce Initiation Of Combination Immunotherapy Clinical Trial Of ONT-10 and Varlilumab

Oncothyreon's (ONTY) CEO Robert Kirkman on Q3 2014 Results - Earnings Call Transcript

UPDATE: H.C. Wainwright & Co. Initiates Coverage On Oncothyreon On Significant Upside

See More ONTY News...

ONTY's Top Competitors

ONTY $1.60 (-1.84%)
Current stock: ONTY
AMGN $158.74 (0.11%)
Current stock: AMGN
GILD $103.39 (0.58%)
Current stock: GILD
BIIB $415.33 (0.62%)
Current stock: BIIB